IV 111th CONGRESS 2d Session H. RES. 1444 IN THE HOUSE OF REPRESENTATIVES June 15, 2010 Mr. Pallone (for himself and Mr. Shimkus) submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Recognizing the 60th anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases.

Whereas the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads the Nation’s Federal commitment to research, research training, and science-based education and health information dissemination with respect to diabetes and other endocrine and metabolic diseases, digestive and liver diseases, nutritional disorders, obesity, kidney diseases, urologic diseases, and hematologic diseases; Whereas the Institute was originally established in 1950 through the Omnibus Medical Research Act as the National Institute of Arthritis and Metabolic Diseases, was renamed several times during the ensuing decades, and was renamed in 1986 as the National Institute of Diabetes and Digestive and Kidney Diseases; Whereas the chronic and costly diseases and disorders within the Institute’s mission together affect millions of Americans, and range from some of the Nation’s most common diseases and disorders to those which are more rare; Whereas the Institute supports research by extramural scientists at academic and other medical research institutions across the Nation, as well as research by scientists in the Institute’s intramural program; Whereas the Institute supports basic, clinical, population, and translational research in laboratory, clinic, and community settings throughout the country; Whereas the NIDDK pursues research efforts to benefit all individuals burdened by diseases and disorders within the Institute’s mission, including both men and women, older and younger adults, children, minority populations who are disproportionately affected by many of these diseases, and people from economically disadvantaged backgrounds; Whereas NIDDK-supported research discoveries have dramatically increased vital understanding of the biologic mechanisms and behavioral and environmental factors that contribute to health and disease—knowledge which has propelled the development of intervention strategies; Whereas research conducted and supported by the NIDDK has been instrumental in revolutionizing prevention, diagnosis, and treatment strategies for individuals who have, or are at risk for, diseases and disorders within the Institute’s mission, leading to remarkable improvements in health and quality of life; Whereas the NIDDK has been a leader in research training and mentoring efforts, from summer programs for high school and college students with special opportunities for underrepresented minorities, to fellowships for graduate and medical students and postdoctoral researchers, to support for early-career and established investigators, in order to ensure that critical biomedical research will continue into the future; Whereas the Institute additionally sponsors education and outreach programs, with materials tailored for diverse audiences, to improve health by disseminating science-based information to patients and their families, those at risk for disease, health care professionals, and the general public; Whereas the Institute has been a leader in collaborative and coordinated research efforts and science-based education programs, in order to maximize the Federal investment in research and synergize expertise across the National Institutes of Health, with other Federal agencies, and with public and private organizations; Whereas the burden of diabetes, endocrine and metabolic diseases, digestive diseases, nutritional disorders, obesity, and kidney, urologic, and hematologic diseases remains a public health challenge for the Nation; and Whereas NIDDK-supported investigators continue to make strides in research toward understanding, preventing, and treating type 1 diabetes; type 2 diabetes; gestational, monogenic, and other forms of diabetes, and diabetic complications; other endocrine and metabolic diseases, including cystic fibrosis, osteoporosis, and lysosomal storage disorders; digestive diseases, including those affecting the gastrointestinal tract, pancreas, liver, and biliary system; inflammatory bowel disease; nutritional disorders, including Celiac disease; obesity; kidney diseases, including chronic kidney disease and acute kidney injury, polycystic kidney disease, focal segmental glomerulosclerosis, end-stage renal disease, and other kidney diseases; urologic diseases and disorders, such as urinary incontinence, urinary tract infections, interstitial cystitis/painful bladder syndrome, chronic prostatitis/chronic pelvic pain syndrome, and kidney stones; and hematologic diseases, including anemias and other blood disorders: Now, therefore, be it

That the House of Representatives— (1)commemorates the 60th anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and commends the Institute for its leadership in research, research training, and science-based education programs; (2)recognizes— (A)the Institute-supported extramural and intramural scientists whose studies have improved human health, and whose research continues to yield promising discoveries; (B)the volunteers who participate in clinical studies; and (C)the patient and professional health organizations who contribute to the shared research goals of preventing, treating, and curing the diseases and disorders within the Institute’s mission; and (3)reaffirms support for the NIDDK and its continued commitment to research to improve health.